Quantgene
Santa Monica, California, United States
Quantgene has developed a method for Deep Human Genome sequencing which allows the visualisation of mutational patterns of disease down to a single molecule. The GRIFFIN Deep Genomics Platform enables the profiling of cfDNA in a patient’s blood with near-absolute precision. This helps inform early cancer detection, prediction of disease onset as well as non-invasive treatment monitoring for longer healthier lives.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2017
- Website
- quantgene.com/
Categories
Only accessible to MedStartr community members.
Join nowWhat do you think of Quantgene?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now